NASDAQ:CNTB
Connect Biopharma Holdings Limited
- Stock
Last Close
1.36
26/07 20:00
Market Cap
68.88M
Beta: −0.54
Volume Today
20.54K
Avg: 344.89K
PE Ratio
−0.56
PFCF: −0.63
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -61.92M - | -30.84K 99.95% | -56.68M 183,664.52% | -15.43K 99.97% | -30.58M 198,068.71% | -15.23K 99.95% | -14.81K 2.77% | |
depreciation and amortization | 502.72K - | 286.52 99.94% | 527.30K 183,931.76% | 255.40 99.95% | 506.13K 198,068.63% | 253.61 99.95% | 246.64 2.75% | |
deferred income tax | -0.00 - | 0.00 - | ||||||
stock based compensation | 1.49K - | 1.17K - | 528.58 - | 496.64 6.04% | ||||
change in working capital | 5.59M - | 2.60K 99.95% | 1.43M 54,776.68% | -628.60 100.04% | -1.72M 272,938.40% | 936.14 100.05% | 953.31 1.83% | |
accounts receivables | -237.78K - | 2.13K 100.90% | 3.54M 166,010.02% | -232.83 100.01% | -461.40K 198,068.70% | 741.14 100.16% | 747.50 0.86% | |
inventory | 1 - | 1 - | ||||||
accounts payables | 3.36M - | -2.99M - | 15.00K - | |||||
other working capital | 2.47M - | 467.51 99.98% | 876.45K 187,371.77% | -395.77 100.05% | -1.27M 320,775.60% | 195.00 100.02% | 205.81 5.54% | |
other non cash items | 2.97M - | -229.13 100.01% | 10.24M 4,468,418.86% | -1.05K 100.01% | 704.37K 67,070.75% | 4.31K 99.39% | 4.34K 0.67% | |
net cash provided by operating activities | -52.85M - | -26.69K 99.95% | -44.49M 166,564.89% | -15.69K 99.96% | -31.09M 198,068.70% | -9.20K 99.97% | -8.77K 4.66% | |
investments in property plant and equipment | -1.74M - | -1.41K 99.92% | -2.46M 174,278.94% | -144.16 99.99% | -285.67K 198,068.41% | -11.32 100.00% | -7.38 34.77% | |
acquisitions net | ||||||||
purchases of investments | -80.55M - | -30.94M - | -30.96M - | |||||
sales maturities of investments | 6.48M - | 27.39M - | 65.50M - | |||||
other investing activites | -7.18K - | 17.43K - | -1 100.01% | 21.32K 2,132,200% | 20.84K 2.23% | |||
net cash used for investing activites | -75.81M - | -8.59K 99.99% | -6.00M 69,785.07% | 17.28K 100.29% | 34.25M 198,073.33% | 21.31K 99.94% | 20.84K 2.21% | |
debt repayment | ||||||||
common stock issued | 116.96K - | 10.49K - | 22.07K - | |||||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | -58.52 - | -135.18K 230,885.58% | -65.74 99.95% | -152.36K 231,644.61% | -61.12 99.96% | -59.33 2.94% | ||
net cash used provided by financing activities | 35.18K - | -58.52 100.17% | -124.69K 212,952.76% | -65.74 99.95% | -130.28K 198,068.67% | -61.12 99.95% | -59.33 2.94% | |
effect of forex changes on cash | 2.54M - | -5.73K 100.23% | -11.96M 208,519.24% | 1.34K 100.01% | -1.01M 75,573.11% | -1.25K 99.88% | -1.29K 2.92% | |
net change in cash | -126.09M - | -41.07K 99.97% | -62.57M 152,243.54% | 2.87K 100.00% | 2.02M 70,383.73% | 10.80K 99.47% | 10.72K 0.73% | |
cash at beginning of period | 267.82M - | 141.60K 99.95% | 141.73M 99,988.48% | 79.16M - | -0.32 100.00% | -0.86 171.70% | ||
cash at end of period | 141.73M - | 100.53K 99.93% | 79.16M 78,639.43% | 2.87K 100.00% | 81.18M 2,829,197.95% | 10.80K 99.99% | 10.72K 0.73% | |
operating cash flow | -52.85M - | -26.69K 99.95% | -44.49M 166,564.89% | -15.69K 99.96% | -31.09M 198,068.70% | -9.20K 99.97% | -8.77K 4.66% | |
capital expenditure | -1.74M - | -1.41K 99.92% | -2.46M 174,278.94% | -144.16 99.99% | -285.67K 198,068.41% | -11.32 100.00% | -7.38 34.77% | |
free cash flow | -54.59M - | -28.10K 99.95% | -46.94M 166,951.81% | -15.83K 99.97% | -31.37M 198,068.70% | -9.21K 99.97% | -8.78K 4.69% |
All numbers in USD (except ratios and percentages)